HIMS Stock Analysis | Hims Hers Health Inc RSI, Financials, Earnings & Insider Data

Moving averages

SMA 50$29.04-4.68%

SMA 200$27.39+1.06%

EMA 20$28.76-3.76%

Company profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Market cap$7.21B

P/E ratioNone

EPS$-0.64

Beta2.432

Dividend yield0.00%

52-week high$65.30

52-week low$13.74

Insider transactions

Executive	Title	Action	Shares	Date
BOUGHTON, SOLEIL	Chief Legal Officer	S	3,462	2026-10-28
BOUGHTON, SOLEIL	Chief Legal Officer	S	3,461	2026-10-14
OKUPE, OLUYEMI	Chief Financial Officer	S	2,000	2026-10-01

Continue with Google

Sign in: free for 30 days

Latest news

HIMS DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urges Hims & Hers Health, Inc. Investors to Contact the Firm Before November 2nd

Bearish Carroll County Mirror-Democrat 2 days ago

Hims & Hers Health 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Bearish Business Wire 2 days ago

What Should Hims & Hers Health, Inc. Investors Know After 14.73% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline

Bearish Morningstar 3 days ago

Earnings call transcript

Q2 2026

Hello, everyone. Thank you for joining us and welcome to the Hims & Hers Health Second Quarter 2026 earnings call. I will now turn the conference over to Bill Newby, Director of Investor Relations. Bill, please go ahead.…

Continue with Google

Sign in: free for 30 days

Options chain

Type	Strike	Expiry	Volume	Open interest
Call	$28.50	2026-10-30	10,452	9,591
Call	$30.00	2026-10-30	10,447	14,168
Call	$28.00	2026-11-06	7,183	722

Continue with Google

Sign in: free for 30 days

ETFs holding HIMS

IWM 0.37% of the fund RSI 49

Similar stocks in Drug Manufacturers - Specialty & Generic

CGC Canopy Growth Corporation RSI 25 BFRI Biofrontera Inc RSI 42 TLRY Tilray Brands Inc - Class 2 RSI 18 LNTH Lantheus Holdings Inc RSI 56 BCRX Biocryst Pharmaceuticals Inc RSI 55 ACB Aurora Cannabis Inc RSI 50 ORGO Organogenesis Holdings Inc - Class A RSI 16 INM InMed Pharmaceuticals Inc RSI 71

30 days of PRO Unlimited free, no card

RSI alerts for HIMS

An email when HIMS closes below RSI 30 or above 70. Nothing else.

Add alert